Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized study-Reference-Cited by-同舟云学术

Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized study

Published:2014-01 Issue:1 Volume:25 Page:160-165
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Fotopoulou C.,Vergote I.,Mainwaring P.,Bidzinski M.,Vermorken J.B.,Ghamande S.A.,Harnett P.,Del Prete S.A.,Green J.A.,Spaczynski M.,Blagden S.,Gore M.,Ledermann J.,Kaye S.,Gabra H.

Funder

Imperial

College's Experimental Cancer Medicine Center (ECMC), Cancer Research UK (CRUK) Clinical Center and Biomedical Research Centre

NIHR Biomedical Research Centre at the Royal Marsden NHS Foundation Trust and Institute of Cancer Research

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/25/1/160/16701643/mdt515.pdf

Reference28 articles.

1. Surgery for ovarian cancer: how to improve survival;Bristow;Lancet,2006

2. Role of chemotherapy in relapsed ovarian cancer;Colombo;Crit Rev Oncol Hematol,1999

3. Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin;Markman;J Clin Oncol,1991

4. Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules to patients with relapsed, platinum-sensitive, advanced ovarian cancer;Del Campo;Ann Oncol,2009

5. Dose density and altered scheduling of adjuvant chemotherapy in ovarian cancer: teaching old dogs new tricks?;Gabra;Discov Med,2009

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of target agent treatment strategies for platinum-resistant recurrent ovarian cancer: A Bayesian network meta-analysis;Medicine;2024-05-24

2. The efficacy of tyrosine kinase inhibitors combined with chemotherapy for recurrent ovarian cancer: a systematic review and network meta-analysis;Minerva Biotechnology and Biomolecular Research;2024-05

3. Treatment options for recurrent platinum-resistant ovarian cancer: A systematic review and Bayesian network meta-analysis based on RCTs;Frontiers in Oncology;2023-04-11

4. Recent Insights into Therapeutic Potential of Plant-Derived Flavonoids against Cancer;Anti-Cancer Agents in Medicinal Chemistry;2022-12

5. Recording and reporting of recruitment strategies in trial protocols, registries, and publications was nonexistent;Journal of Clinical Epidemiology;2022-12